Marymount University
Arlington, VA
Wilson Sonsini is proud to sponsor The Accelerate Investor Conference during DC Startup & TechWeek. The Accelerate Investor Conference is a premier event highlighting the Mid-Atlantic region (DC, Maryland, and Virginia) as a hub for innovation and business opportunity. This conference drives innovation by connecting top-tier tech startups with investors, fostering growth and development within the region. Michael Labriola will be delivering the keynote address, followed by Mark Holloway moderating a panel discussion.
Keynote: “The State of the VC Industry: Important Trends & Insights to Watch”
A deep dive into proprietary venture capital and angel investment research and data led by Michael Labriola, Partner, Wilson Sonsini
Panel: “Mid-Atlantic Perspectives in Early Stage Investment”
Alison Perez, Senior Investment Manager, Lockheed Martin Ventures
Brian Smith, Senior Partner, IQT
Tom Weithman, Chief Investment Officer , VIPC, & Managing Director, Virginia Venture Partners
Moderator: Mark Holloway, Partner, Wilson Sonsini
Estelle Ekpo
eekpo@wsgr.comMichael Labriola is a partner with Wilson Sonsini Goodrich & Rosati, where he counsels public and private technology, life sciences, and emerging growth companies through all stages of their growth. Michael has particular experience with Wilson Sonsini’s clients across the U.S. East Coast and Europe. He has a particular focus on supporting companies that undertake transformative events, such as growth financings, IPOs, acquisitions, and exit sales. Michael counsels clients in matters ranging from formation and early-stage venture financing to listings of publicly traded securities on U.S. and foreign exchanges to seasoned public offerings and private and public company acquisitions. He also has considerable experience in counseling publicly held companies on disclosure matters, SEC compliance, Nasdaq and NYSE listing matters, and other securities laws issues. In addition, Michael frequently represents investment banks, venture capital funds, and private equity firms in a broad range of investment transactions.
Mark counsels public and private tech and life sciences companies through all stages of growth and focuses on strategic transactions.